Tangjian Cheng

1.0k citations
15 papers · 926 indexed · h-index 14
Topics
Nanoparticle-Based Drug Delivery (11 papers)Nanoplatforms for cancer theranostics (7 papers)Polymer Surface Interaction Studies (3 papers)
Partner nations
ChinaNetherlandsFrance

In The Last Decade

Tangjian Cheng

15 papers receiving 921 citations

Peers

Tangjian Cheng
Comparison fields: 5 of 94
  • Biomedical Engineering 465
  • Biomaterials 365
  • Molecular Biology 278
  • Materials Chemistry 274
  • Organic Chemistry 163
Replace Gujie Mi with:
Gujie Mi United States
Chenhong Wang China
Liping Chu China
Evgenia Korzhikova‐Vlakh Russia
Long Xu China
Fengyi Cao China
Jun F. Liang United States
Shazid Md. Sharker Bangladesh
Biyuan Wu China
Nicolò Mauro Italy
Tangjian Cheng relative to Gujie Mi United States Gujie Mi's profile →
Citations per field
00.5×11.5×
Gujie Mi · 1×
Citations per year

Countries citing papers authored by Tangjian Cheng

Since Specialization
Citations

This map shows the geographic impact of Tangjian Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tangjian Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tangjian Cheng more than expected).

Fields of papers citing papers by Tangjian Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tangjian Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tangjian Cheng. The network helps show where Tangjian Cheng may publish in the future.

Co-authorship network of co-authors of Tangjian Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Tangjian Cheng. A scholar is included among the top collaborators of Tangjian Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tangjian Cheng. Tangjian Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 47
2 23
3 30
4 41
5 137
6 26
7 142
8 124
9 75
10 96
11 30
12 49
13 32
14 2
15 72

About Tangjian Cheng

Tangjian Cheng is a scholar working on Biomaterials, Surfaces, Coatings and Films and Biomedical Engineering, having authored 15 papers that have together received 926 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (11 papers), Nanoplatforms for cancer theranostics (7 papers) and Polymer Surface Interaction Studies (3 papers). The work is most often cited by research in Biomaterials (365 citations), Microbiology (86 citations) and Pharmaceutical Science (66 citations). Tangjian Cheng has collaborated with scholars based in China, Netherlands and France. Frequent co-authors include Linqi Shi, Jinjian Liu, Jianfeng Liu, Yumin Zhang, Hanlin Ou, Fan Huang, Yingli An, Yuxun Ding, Rujiang Ma and Liping Chu. Their work appears in journals such as Advanced Functional Materials, Chemical Communications and ACS Applied Materials & Interfaces.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026